Back to News
Market Impact: 0.2
Morgan Stanley Initiates Coverage of IMAX at Overweight
Source: Nasdaq
Analyst InsightsMedia & Entertainment
Morgan Stanley initiated coverage of IMAX on September 24, 2026, with an Overweight recommendation. The positive analyst endorsement could support sentiment toward the cinema-technology company, though the report provides no price target, earnings estimates, or operating-data changes.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
IMAX0.55
More News
- Meta nears first new high in a year as Muse success showcases winning AI strategy
- This stock’s defensive appeal faces a valuation test. Here's where else investors can look
- Imax is a must for movie theaters, making the stock a buy, Morgan Stanley says
- BofA Securities reiterates Buy on Meta stock, $810 price target
- CRH stock hits 52-week low at 83.65 USD
- Nike Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Stop Treating AI Like a Chatbot: What Are Agents, SubAgents, MCP, and Skills, and How Do They Actually Work?
- Earnings-Triggered Research Automations: A Control Guide